SBIR/STTR Research Award

Non-obtrusive tissue manipulation device for treatment of carpal tunnel syndrome

Award identifier 4b7ae7e17364d6529f742d3af126d19c72d238249939e7b1124d72ba898623aaAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,602,799

Program and phase

SBIR · Phase II – Direct to Phase II

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PRESSURE PROFILE SYSTEMS, INC.
Proposal award date
2017-06-15
Contract end date
2020-05-31
UEI
Not reported
Solicitation number
PA18-591
Topic code
NIBIB

Research abstract

ABSTRACTCarpal tunnel syndromeCTSis one of the most widely recognized occupational health conditionsDomesticallythe condition affectsof adultsAccording to areport from the Bureau of Labor StatisticsCTS is associated with the second longest average time away from workdaysof all major disabling diseases and illnesses in all private industriesThe cumulative economic cost is in excess of $billion annuallymaking this the most expensive peripheral neuropathy in the United StatesCurrentlycarpal tunnel releaseCTRsurgery is indicated in almost all patients with moderate to severe CTSCTR surgery involves division of the transverse carpal ligamentTCLThis surgery reduces pressure on the median nerve by increasing the volume of the carpal tunnelUnfortunatelysurgery is invasive and has a large incidence of symptom recurrence and morbidityUp toof CTR surgery patients report poor to fair strength and long term discomfortandhave recurrence of some pre operative symptoms beginning an average of two years after surgeryIn recent yearsbrace like ligament tensioning devices that attempt to emulate the effects of surgery have emergedbut these devices have had limited success due to the uncomfortable high forces required to manipulate ligament tissues and the lack of compliance due to their obtrusive designA novel approach to providing long duration tensioning to carpal tunnel ligaments without reliance on excessive force and or cumbersome design would be highly desirable as an alternative to CTR surgeryThis Phase II SBIR project will continue development of a Carpal Tunnel Tissue Manipulation DeviceCTMDthat uses negative pressure to relieve compression on the median nerve without excessive force or cumbersome designsUnlike the majority of traditional and dynamic splintsthe proposed device allows for free movement of the wrist with minimal impediment during daily activitiesOur self funded Phase I efforts involved multiple design iterations until a working prototype was ready for a clinical trialWe then evaluatedweeks of CTMD treatment inpatients with mild to severe CTSThe study showed that the CTMD reduced CTS symptoms at the end of treatmentweeksand improvement continued or was maintainedmonths after treatmentas determined by the Boston Carpal Tunnel QuestionnaireBCTQSymptom Severity ScaleSSSIn this projectthe CTMD prototype will be refined to fit more people and will be validated in a largerlonger clinical trialIn AimPPS will finely tune the design specifications of the CTMD to fit more patients with input from magnetic resonance imagingMRIand pressure profile measurements in humans and cadaversIn Aimthe new design will be investigated in asubjectmulti sitesingle blindedrandomized controlled trial that compares the CTMD to a placebo controlUltimatelythis device could provide a noninvasivesimple and easy to uselow cost alternative to surgery for the millions that suffer from CTS PROJECT NARRATIVE Carpal tunnel syndromeCTSis one of the most widely recognized occupational health conditionsit affectspercent of adults in the United StatesThis project involves refinement of the Carpal Tunnel Tissue Manipulation DeviceCTMDfollowed by a multi siteplacebo controlled clinical trial to validate its effectivenessThe CTMD is novel because it relieves pressure on the median nerve without reliance on surgery or a cumbersome splint designThe CTMD could be a simpleeasy touseand non invasive treatment of CTSwhich could result in long lasting symptom relief to patients and reduced cost to employers and the health care system

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.